Abstract
Objective
To investigate whether hormone therapy (HT) and obesity are associated with endometrial cancer risk among postmenopausal women in the California Teachers Study cohort.
Methods
Of 28,418 postmenopausal women, 395 developed type 1 endometrial cancer between 1995 and 2006. Multivariate Cox regression was performed to estimate relative risks (RR), stratified by HT use (never used, ever estrogen alone (ET) or exclusively estrogen-plus-progestin (EPT)).
Results
Among women who never used HT, overall and abdominal adiposity were associated with increased risk; when evaluated simultaneously, abdominal adiposity was more strongly associated (RR 2.2, 95% confidence interval (CI): 1.1–4.5 for waist ≥35 vs. <35 inches). Among women who ever used ET, risk was increased in women with BMI ≥ 25 kg/m2 (RR 1.6, 95% CI: 1.1–2.3 vs. <25 kg/m2). Neither overall nor abdominal obesity was associated with risk in women who exclusively used EPT (p-interaction <0.001 for BMI by HT use).
Conclusions
Among women who never used HT, risk was strongly positively related to obesity and may have been influenced more by abdominal than by overall adiposity; however, due to small numbers, this latter finding requires replication. Among women who ever used ET, being overweight at baseline predicted higher risk, whereas use of EPT mitigated any effects of obesity.
Similar content being viewed by others
References
Akhmedkhanov A, Zeleniuch-Jacquotte A, Toniolo P (2001) Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives. Ann N Y Acad Sci 943:296–315
Tinelli A, Vergara D, Martignago R, Leo G, Malvasi A, Tinelli R (2008) Hormonal carcinogenesis and socio-biological development factors in endometrial cancer: a clinical review. Acta Obstet Gynecol Scand 87:1101–1113
World Cancer Research Fund and the American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington, DC
Kaaks R, Lukanova A, Kurzer MS (2002) Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 11:1531–1543
Key TJ, Allen NE, Verkasalo PK, Banks E (2001) Energy balance and cancer: the role of sex hormones. Proc Nutr Soc 60:81–89
Kaye SA, Folsom AR, Soler JT, Prineas RJ, Potter JD (1991) Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int J Epidemiol 20:151–156
Potischman N, Swanson CA, Siiteri P, Hoover RN (1996) Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 88:756–758
Lukanova A, Lundin E, Micheli A et al (2004) Circulation levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer 108:425–432
Smith DC, Prentice R, Thompson DJ, Herrmann WL (1975) Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 293:1164–1167
Ziel HK, Finkle WD (1975) Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 293:1167–1170
Mack TM, Pike MC, Henderson BE et al (1976) Estrogens and endometrial cancer in a retirement community. N Engl J Med 294:1262–1267
Mahboubi E, Eyler N, Wynder EL (1982) Epidemiology of cancer of the endometrium. Clin Obstet Gynecol 25:5–17
Shields TS, Weiss NS, Voigt LF, Beresford SA (1999) The additional risk of endometrial cancer associated with unopposed estrogen use in women with other risk factors. Epidemiology 10:733–738
Collaborators MWS, Beral V, Bull D, Reeves G (2005) Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 365:1543–1551
Lacey JV Jr, Brinton LA, Lubin JH, Sherman ME, Schatzkin A, Schairer C (2005) Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 14:1724–1731
Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333
Emons G, Fleckenstein G, Hinney B, Huschmand A, Heyl W (2000) Hormonal interactions in endometrial cancer. Endocr Relat Cancer 7:227–242
Liu FS (2007) Molecular carcinogenesis of endometrial cancer. Taiwan J Obstet Gynecol 46:26–32
Bernstein L, Allen M, Anton-Culver H et al (2002) High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control 13:625–635
Kwong SL, Perkins CI, Morris CR et al (2001) Cancer in California: 1988–1999. California Department of Health Services, Cancer Surveillance Section, Sacramento, CA
Molarius A, Seidell JC (1998) Selection of anthropometric indicators for classification of abdominal fatness—a critical review. Int J Obes Relat Metab Disord 22:719–727
Breslow NE, Day NE (1980) Statistical methods in cancer research. Volume I—The analysis of case-control studies. International Agency for Research on Cancer, Lyon
Razavi P, Pike MC, Horn-Ross PL, Templeman C, Bernstein L, Ursin G (2010) Long-term postmenopausal hormone therapy and endometrial cancer. Cancer Epidemiol Biomarkers Prev 19:475–483
Friedenreich C, Cust A, Lahmann PH et al (2007) Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Cancer Causes Control 18:399–413
McCullough ML, Patel AV, Patel R et al (2008) Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol Biomarkers Prev 17:73–79
Chang SC, Lacey JV Jr, Brinton LA et al (2007) Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev 16:723–730
Parazzini F, La Vecchia C, Bocciolone L, Franceschi S (1991) The epidemiology of endometrial cancer. Gynecol Oncol 41:1–16
Folsom AR, Kaye SA, Potter JD, Prineas RJ (1989) Association of incident carcinoma of the endometrium with body weight and fat distribution in older women: early findings of the Iowa Women’s Health Study. Cancer Res 49:6828–6831
Acknowledgments
This research was supported by grant R01 CA77398 from the National Cancer Institute and contract 97-10500 from the California Breast Cancer Research Fund. The funding sources did not contribute to the design or conduct of the study, nor to the writing or submission of this manuscript. The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer-reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute’s Surveillance, Epidemiology and End Results Program under contract N01-PC-35136 awarded to the Cancer Prevention Institute of California (formerly the Northern California Cancer Center), contract N01-PC-35139 awarded to the University of Southern California, and contract N02-PC-15105 awarded to the Public Health Institute; and the Centers for Disease Control and Prevention’s National Program of Cancer Registries under agreement #U55/CCR921930-02 awarded to the Public Health Institute. The ideas and opinions expressed herein are those of the authors, and endorsement by the State of California, Department of Public Health, the National Cancer Institute and the Centers for Disease Control and Prevention or their contractors and subcontractors is not intended nor should be inferred. The authors would like to thank the CTS Steering Committee who are responsible for the formation and maintenance of the cohort within which this study was conducted but who did not directly contribute to the current paper: Hoda Anton-Culver, Christina A. Clarke, Rosemary Cress, Katherine D. Henderson, Susan L. Neuhausen, Rich Pinder, Daniel O. Stram, Dee W. West and Argyrios Ziogas.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Canchola, A.J., Chang, E.T., Bernstein, L. et al. Body size and the risk of endometrial cancer by hormone therapy use in postmenopausal women in the California Teachers Study cohort. Cancer Causes Control 21, 1407–1416 (2010). https://doi.org/10.1007/s10552-010-9568-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-010-9568-8